To confirm whether HOXB5 correlated with the proliferation of glioma, we firstly performed qRT-PCR and western blotting to detect the efficiency of HOXB5 knockdown or overexpression (Fig. S2c–f). The gene discussed is HOXB5; the disease is central nervous system cancer.